Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (3): 374-378    DOI: 10.12891/ceog3516.2017
Original Research Previous articles | Next articles
Management of placenta accreta in an Australian tertiary referral centre: a ten-year experience
D.R. Listijono1, 2, S.C. Chuah3, F. Rahimpanah1, 3()
1 School of Women's and Children's Health, University of New South Wales, Sydney, Australia
2 Department of Women's and Children's Health, St George Hospital, Kogarah, Sydney, Australia
3 Obstetrics & Gynaecology Department, Liverpool Hospital, Sydney, Australia
Download:  PDF(308KB)  ( 75 )
Export:  BibTeX | EndNote (RIS)      
Abstract  Purpose of investigation: To report a ten-year experience in management of a highly morbid obstetrical condition in placenta accreta (PA) at a tertiary referral centre, uniquely equipped with an integrated Interventional Radiology theatre, with a primary aim to guide best practice. Materials and Methods: Retrospective analysis of all histologically proven PA cases at a tertiary centre in Australia between January 2004 and December 2013. Medical records were reviewed for obstetrics history, operative details, post-operative management and neonatal outcome. Results: Sixteen cases of PA were identified during the time period; 75% had identifiable risk factors for PA and 87.5% of patients were diagnosed antenatally. Mean gestational age at time of delivery was 34 ± 3.4 weeks. Ten cases were performed electively, while the remaining underwent emergency caesarean section. One patient was managed conservatively with placenta left insitu; time to complete resolution of placenta was 71 days. Among patients who underwent hysterectomy (15/16), the proportion of total (n=8) vs. subtotal (n=7) hysterectomy was similar. Average operating time was 123 ± 45.9 minutes. Compared to emergency cases, patients who underwent elective surgery had significantly lower blood loss (2.2 vs. 3.1 L, p < 0.05). Common iliac artery balloons were deployed in eight cases, with a non-statistically significant reduction in intraoperative blood loss (2 vs. 3.2 L, p < 0.05). Fifty percent of patients required ICU admission. Neonatal survival at six months was 93.75% (15/16). Conclusion: The present report demonstrates the importance of timely diagnosis and comprehensive preparation in the surgical management of patients with placenta accreta. The availability of relevant services in the peri-operative phase, including: obstetricians, interventional radiology facility and personnel, intensive care, and neonatology teams, are crucial in achieving optimal outcome for the patient and neonate. In line with reports in the literature, the authors advocate a team-based multidisciplinary approach in a tertiary-level centre for management of this high-risk condition.
Key words:  Placenta accreta      Multidisciplinary      Teamwork      Caesarean hysterectomy     
Published:  10 June 2017     
*Corresponding Author(s):  F. RAHIMPANAH     E-mail:  frahimpanah@hotmail.com

Cite this article: 

D.R. Listijono, S.C. Chuah, F. Rahimpanah. Management of placenta accreta in an Australian tertiary referral centre: a ten-year experience. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 374-378.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3516.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I3/374

[1] Mahmoud Alalfy, Soha Talaat Hamed, Alaa Sobhi Abd El Ghani, Ahmed Elgazzar, Amr Abbassy, Ahmed S. S. A. Rashwan, Omar Nagy, Mohamed A Shalaby, Hatem Hassan, Asmaa Ibrahem, Hesham Kamal, Reham Mahrous, Eman Kamal. The accuracy of 3D-TUI and 3D power Doppler using Alalfy simple criteria in the diagnosis of placenta accreta spectrum[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1132-1140.
[2] Mengdie Luo, Junxing Li, Xiaofeng Yang, Qiang Huang, Mengwei Huang, Jie Mei. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta spectrum disorder[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 487-493.
[3] Eren Akbaba. Can high transverse skin incision (Modified Maylard) be a new alternative in placenta accreta spectrum management with cesarean hysterectomy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 686-690.
[4] Yu Huang, Fang-Yuan Luo. Clinical efficacy of aortic balloon occlusion during caesarean section in patients with placenta accreta spectrum disorders: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 234-244.
[5] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception with enhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[6] K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.
[7] Z.R. Zheng, X. Xie, Y. Hou, P. Xie, X. Yu, L. Xie. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 704-708.
[8] X.W. Sun, X.M. Bai, Q. Chen, J.F. Shen, L. Yang, J.Y. Zhang, X.S. Gu, Q. Yuan, J. Jing, Y. Jin. Preset catheter sheaths for uterine arterial embolization in the cesarean section of pernicious preplacental placenta: its application[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 108-112.
[9] A. Tsiola, D. Marioli, I. Papadimitriou, V. Tsapanos, N. A. Georgopoulos. Increased kisspeptin mRNA expression derived from abnormally adhered placenta: compensatory inhibition of abnormal placental invasion?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 204-208.
[10] H. Kyozuka, K. Takiguchi, A. Owada, Y. Endo, M. Kojima, S. Suzuki, K. Fujimori. Two cases of placenta accreta with conservative management[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 283-286.
[11] A. Okada, K. Tanaka, K. Kajitani, S. Nishimoto, H. Nakamura, O. Nakamoto. Near-infrared spectroscopy during cesarean section with common iliac artery balloon occlusion for total placenta previa: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 112-114.
[12] H. Takahashi, R. Usui, H. Suzuki, Y. Baba, T. Suzuki, T. Kuwata, A. Ohkuchi, S. Matsubara. Uterine-fundal hypoechoic mass: a possible ultrasound sign for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 88-92.
[13] S. Matsuzaki, K. Yoshino, T. Tomimatsu, T. Takiuchi, K. Kumasawa, T. Kimura. Placenta accreta following laparoscopic adenomyomectomy: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(5): 763-765.
[14] M. Sakinci, O. Kuru, M. Tosun, A. Karagoz, H. Celik, F.D. Bildircin, E. Malatyalioglu. Clinical analysis of emergency peripartum hysterectomies in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(6): 654-658.
[15] G. Di Luigi, F. Patacchiola, L. Di Stefano, A. D’Alfonso, A. Carta, G. Carta. Placenta accreta: conservative approach[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(4): 596-598.
No Suggested Reading articles found!